Latest Financial Results
Q3 FY26
Quarter Ended Mar 31, 2026
Latest News
Highlights
- Target markets are very large and significantly underpenetrated.
- Resmed is well-positioned with differentiated products, a robust innovation pipeline, and supply chain flexibility.
- Key mega trends in big tech and pharma are driving patients to our sleep ecosystem.
- Strong revenue growth and operating leverage delivered a year-over-year growth in free cash flow.
- Balance sheet is very strong.
- Experienced management team has successfully delivered long-term growth and navigated externalities including COVID, supply chain perturbations, and 5-year exit of a peer from US device market.
- Industry advocacy via AdvaMed volunteer chairman and other team leadership roles.
- Strong brand built through high-quality products and customer service levels has supported Resmed's market-leading position.
Email Alerts
Sign up today and receive company updates straight to your inbox.
IR Contacts
Headquarters
ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123
Investor Relations
ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123
Phone: 858-221-3304
InvestorRelations@resmed.com
Transfer Agent
Computershare, Inc.
PO Box 30170
College Station, TX 77842
USA
Phone: 800-962-4284
https://www.computershare.com/us
Computershare, Inc.
Level 3
60 Carrington Street
Sydney NSW 2000
Australia
Phone: +61 2 8234 5000
https://www.computershare.com/au